SENHWA BIOSCIENCES
Senhwa Biosciences identifies and develops innovative therapies that have the potential to fundamentally change the way patients are treated. Our central philosophy is to unearth validated targets or therapies that could significantly improve treatment, but have not yet been properly exploited. As a value-added development company, Senhwa aims to take innovative therapies that could impact the current standard of care and drive them through to clinical proof-of-concept.
SENHWA BIOSCIENCES
Industry:
Biotechnology Developer Platform Health Care
Founded:
2013-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.senhwabiosciences.com
Total Employee:
1+
Status:
Active
Contact:
8585526808
Total Funding:
17 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Amazon CloudFront OpenResty Google Adsense AWS Global Accelerator AdBlock Acceptable Ads
Similar Organizations
Aratana Therapeutics
Aratana Therapeutics develops innovative therapies for the animal health industry.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Current Employees Featured
Benny Hu Chairman @ Senhwa Biosciences
Chairman
Tai-Sen Soong CEO, Founder @ Senhwa Biosciences
CEO, Founder
Founder
Investors List
WI Harper Group
WI Harper Group investment in Series B - Senhwa Biosciences
Morningside Group
Morningside Group investment in Series B - Senhwa Biosciences
China Investment & Development
China Investment & Development investment in Series B - Senhwa Biosciences
H&Q Asia Pacific
H&Q Asia Pacific investment in Series B - Senhwa Biosciences
Official Site Inspections
http://www.senhwabiosciences.com
- Host name: 104.21.112.1
- IP address: 104.21.112.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Senhwa Biosciences"
Company Profile-Senhwa Biosciences, Inc.
Core Value. Senhwa has a strong Management Team with proven track records in developing new drugs and targeted agents. Headquartered in Taiwan, but with a vital operational base in …See details»
Company Profile - Senhwa Biosciences, Inc.
Company Profile Company Profile Senhwa Biosciences, Inc was established in 2012 and aims to transform the model for new drug development by focusing on human efficacy.See details»
Home | Senhwa Biosciences, Inc.
One Drug with Multi-target Therapy Senhwa’s Pidnarulex (CX-5461) has proven to be the next generation DDR (DNA Damage Response) drug, with the mechanism of synthetic lethality …See details»
Senhwa Biosciences, Inc. - Drug pipelines, Patents, Clinical trials ...
Www.senhwabiosciences.com. Public Company | 2012 | Taiwan Province, China | ROCO: 6492 | www.senhwabiosciences.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. …See details»
Senhwa Biosciences - Crunchbase Company Profile & Funding
Dec 12, 2013 Senhwa Biosciences identifies and develops innovative therapies that have the potential to fundamentally change the way patients are treated. Our central philosophy is to …See details»
Senhwa Biosciences Company Profile - Office Locations ... - Craft
Oct 4, 2024 See insights on Senhwa Biosciences including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Senhwa Biosciences Inc - Company Profile and News
Company profile page for Senhwa Biosciences Inc including stock price, company news, executives, board members, and contact informationSee details»
Senhwa Biosciences Company Profile: Overview and Full News …
News Summary Senhwa Biosciences, Inc. announced the appointment of Dr. Yiu-Lian Fong to the board of directors for Ding Li Development Ltd. Dr. Fong, a present member of the Bio Taiwan …See details»
Global Office - Senhwa Biosciences, Inc.
Global Office. Headquartered in Taiwan, but with a vital operational base in San Diego, California.See details»
Senhwa Biosciences, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Senhwa Biosciences, Inc. of New Taipei City, New Taipei. Get the latest business insights from Dun & …See details»
Senhwa Biosciences Corporation - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Senhwa Biosciences Corporation of San Diego, CA. Get the latest business insights from Dun & …See details»
Senhwa Biosciences - Overview, News & Similar companies
Senhwa Biosciences contact info: Phone number: (858) 552-6808 Website: www.senhwabiosciences.com What does Senhwa Biosciences do? Senhwa Biosciences, Inc. …See details»
SENHWA BIOSCIENCES Revenue, Growth & Competitor Profile
Senhwabiosciences.com: Note: Revenues for privately held companies are statistical evaluations. Senhwa Biosciences's annual revenues are $1-$10 million (see exact revenue data) and has 1 …See details»
Management team-Senhwa Biosciences, Inc.
Dr. Liu joined Senhwa in November, 2017 and appointed as Director leading R&D department. He is well experienced in drug discovery team structure, patent strategy, CMC and formulation …See details»
Company profile-Senhwa Biosciences, Inc.
Company Profile. Senhwa Biosciences, Inc was established in 2012 and aims to transform the model for new drug development by focusing on human efficacy.See details»
Senhwa Biosciences Reviews | Read Client Reviews of Senhwa …
Read reviews of Senhwa Biosciences. Write and share your personal story. Your experience will help others make the right buying decision.See details»
Company Profile - Senhwa Biosciences, Inc.
Core Value Senhwa has a strong Management Team with a proven track record in developing new drugs and targeted agents. Headquartered in Taiwan, with a vital operational base in San …See details»
Milestones-Senhwa Biosciences, Inc.
Nov. Senhwa Biosciences, Inc. begins operation on Nov. 16, 2012. Senhwa had raised NTD$ 339 million in its first round of fundingSee details»
Senhwa Biosciences, Inc.
Media coverage [Taipei Times]Virus Outbreak: Senhwa Biosciences, NIH working on COVID-19 drug Apr 10, 2020 [The New York Times]Scientists Identify 69 Drugs to Test Against the …See details»